Sepsis & infection

Prehospital lactate analysis in suspected sepsis improves detection of patients with increased mortality risk: an observational study

Crit CarePublished Prospective observational cohort study

Authors' conclusion

The addition of a prehospital lactate level > 3 mmol/l improved early recognition of individuals with increased mortality risk in a cohort with suspected sepsis admitted to the ED. This was particularly evident in patients whose risk stratification scores did not indicate severe illness.

Study context

Population
Adults with suspected sepsis, prehospital inclusion, admitted to the emergency departments (ED)322 (45%) met Sepsis-3
Participants
714 adults
Exposure
Prehospital lactate added to Rapid Emergency Triage and Treatment System (RETTS) and NEWS2 risk stratification
Outcome
30-day mortality
Follow-up
30 days
Methodological detailsconsecutive prospective prehospital inclusion
  • Consecutive prospective prehospital inclusion

Main finding

As reported in the abstract

Odds ratio

2.20

P = 0.009

Lactate > 3 mmol/l · multivariable regression

Prehospital lactate

2.6 vs 2.0 mmol/L

P < 0.001

Non-survivors vs Survivors

Overall 30-day mortality
10%
30-day mortality among Sepsis-3 cases
14%

Observational data: associations, not effects.

Secondary outcomes

OutcomeEstimateP value
30-day mortality, RETTS non-red subgroup · 30 daysLactate > 3 mmol/l · multivariable regressionOR 3.02P = 0.009
30-day mortality, RETTS non-red subgroup · 30 daysNon-survivors vs SurvivorsPrehospital lactate 2.4 vs 1.8 mmol/LP = 0.002
Prehospital lactate by RETTS priorityRETTS red vs RETTS non-redPrehospital lactate 2.5 vs 1.9 mmol/LP < 0.001

Identification of non-survivors when adding lactate > 3 mmol/l

RETTS red group
from 48 to 68%
NEWS2 ≥ 7 group
from 77 to 85%

Original publication

Prehospital lactate analysis in suspected sepsis improves detection of patients with increased mortality risk: an observational study. Crit Care. Published 21 January 2025. doi:10.1186/s13054-024-05225-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.